Antipsychotic medications have dramatically increased in prescriptions, including additional FDA-approved usages for bipolar and depression as well as off-label use. Side effects of these drugs, such as abdominal weight gain, lipid and blood pressure changes, and elevations in fasting glucose, may contribute to metabolic syndrome. What are the impacts of increased use of antipsychotic medications on diabetes? Join host Dr. Steven Edelman and his guest, associate professor of psychiatry at Harvard Medical School, Dr. David Henderson, as they discuss the need for healthcare providers to be proactive: understanding the patient's risk factors, medical history and the risk-benefit ratio in order to treat effectively.
Antipsychotics and Metabolic Syndrome
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Antipsychotic medications have dramatically increased in prescriptions, including additional FDA-approved usages for bipolar and depression as well as off-label use. Side effects of these drugs, such as abdominal weight gain, lipid and blood pressure changes, and elevations in fasting glucose, may contribute to metabolic syndrome. What are the impacts of increased use of antipsychotic medications on diabetes? Join host Dr. Steven Edelman and his guest, associate professor of psychiatry at Harvard Medical School, Dr. David Henderson, as they discuss the need for healthcare providers to be proactive: understanding the patient's risk factors, medical history and the risk-benefit ratio in order to treat effectively.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Updates From the 7th World Symposium Task Force
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">Updates From the 7th World Symposium Task Force</span><span data-ccp-props='{"201341983":0,"335559738":210,"335559739":210,"335559740":240}'> </span></p>
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
1.00 credits
<p>Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D</p>
NeuroFrontiers
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
<p>Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms</p>
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
<p>mIDH Gliomas Explained: Characteristics and Management Strategies</p>
NeuroFrontiers
From Diagnosis to Treatment: Challenges in Glioblastoma Care
<p>From Diagnosis to Treatment: Challenges in Glioblastoma Care</p>
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
<p>Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data</p>
Clinician's Roundtable
Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
<p>Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?